Skip to main content

Trexquant Investment LP

Position in LLY — ELI LILLY & Co

CIK 1633445 STAMFORD, CT

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$108,968,224
+$30,855,837 QoQ
Shares Held
90,850
+7.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#367
of 4,605 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$359,829
CallShares
300
PutValue
$599,715
PutShares
500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $226,269,634 across 5 Drug Manufacturers - General names. LLY ranks #1 (48.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
90,850 $108,968,224

All Filings in LLY

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $108,968,224 90,850
2026-06-30 $359,829 300
2026-06-30 $599,715 500
2026-03-31 $78,112,387 84,926
2026-03-31 $91,977 100
2025-12-31 $32,929,272 30,641
2025-09-30 $19,899,803 26,081
2025-03-31 $11,248,068 13,619
2024-12-31 $3,413,012 4,421
2024-09-30 $2,259,147 2,550
2023-09-30 $3,874,318 7,213
2022-06-30 $2,131,488 6,574
2022-03-31 $8,220,250 28,705
2021-12-31 $10,225,111 37,018
2021-09-30 $6,648,232 28,774
2020-12-31 $2,814,225 16,668
2020-09-30 $5,550,305 37,497
2020-06-30 $4,492,293 27,362
2020-03-31 $2,250,177 16,221